<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000761601"><TermName>selumetinib</TermName><TermPronunciation>(SEL-yoo-MEH-tih-nib)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of several types of cancer. Selumetinib blocks proteins needed for cell growth and may kill cancer cells. It is a type of protein kinase inhibitor. Also called AZD6244 and MEK inhibitor AZD6244.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000762443" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;selumetinib&quot;" language="en" id="_3"/><MediaLink ref="CDR0000762442" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;selumetinib&quot;" language="es" id="_4"/><SpanishTermName>selumetinib</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de varios tipos de cáncer. El selumetinib bloquea las proteínas que la célula necesita para crecer y podría destruir células cancerosas. Es un tipo de inhibidor de la proteína cinasa. También se llama AZD6244 y inhibidor del MEK AZD6244.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2014-05-28</DateFirstPublished><DateLastModified>2008-07-18</DateLastModified></GlossaryTerm>
